Good morning/afternoon/evening, Zolis: I'll sta
Post# of 36536
(Total Views: 535)
Posted On: 01/31/2022 6:15:20 PM
Re: Zolis_onkel #34690
Good morning/afternoon/evening, Zolis:
I'll start with your last point, and go from there...
If the CompleteVaccine technology is so great, I would have expected one of the big pharm companies to associate themselves with Generex (wasn't Merck running with the AE37 and Keytruda? - that's pretty big pharm, IMO), in order to take the lion's share of the market, with a vaccine that puts the others to shame. No. Instead, each company prefers to have a vaccine that has less-than-optimal efficacy, so that they can have competitors who also will share in the pie. Yeah, that makes a lot of sense. Really? If there had been a snowball's chance in hell that a real pharm company thought Ii-key peptide was the better mousetrap, they would have been all over it. Oh, yeah, let's go back to the history of all the actual vaccines that Generex put into actual production and sold (not just "developed," or "worked on"
- what was that number again? ZERO. It's so good it's never been used - wow.
Now,let's talk about the sales of Oralyn, Pantheon Orthopedic Surgical, diagnostic blood assays for syphilis, malaria, etc. Or maybe you'd like to talk about the success of telemedicine locations, especially since we have had the pandemic for almost 2 years, and at this point that is bound to have generated lots of income. Still waiting for those Malaysian purchases to come through for Excellagen, too, but maybe the VA is buying up all the inventory, now that the VA hospitals are open again.
Oh, well, Joe does not give a tinker's dam about these companies, and their shareholders, and refuses to clear up what increasingly appear to be lies told for some indeterminate period. But if you feel betting thinking there is some "better nature" to be appealed to, go ahead. I prefer hard evidence to unicorn tears and rainbow wishes.
I'll start with your last point, and go from there...
If the CompleteVaccine technology is so great, I would have expected one of the big pharm companies to associate themselves with Generex (wasn't Merck running with the AE37 and Keytruda? - that's pretty big pharm, IMO), in order to take the lion's share of the market, with a vaccine that puts the others to shame. No. Instead, each company prefers to have a vaccine that has less-than-optimal efficacy, so that they can have competitors who also will share in the pie. Yeah, that makes a lot of sense. Really? If there had been a snowball's chance in hell that a real pharm company thought Ii-key peptide was the better mousetrap, they would have been all over it. Oh, yeah, let's go back to the history of all the actual vaccines that Generex put into actual production and sold (not just "developed," or "worked on"
- what was that number again? ZERO. It's so good it's never been used - wow. Now,let's talk about the sales of Oralyn, Pantheon Orthopedic Surgical, diagnostic blood assays for syphilis, malaria, etc. Or maybe you'd like to talk about the success of telemedicine locations, especially since we have had the pandemic for almost 2 years, and at this point that is bound to have generated lots of income. Still waiting for those Malaysian purchases to come through for Excellagen, too, but maybe the VA is buying up all the inventory, now that the VA hospitals are open again.
Oh, well, Joe does not give a tinker's dam about these companies, and their shareholders, and refuses to clear up what increasingly appear to be lies told for some indeterminate period. But if you feel betting thinking there is some "better nature" to be appealed to, go ahead. I prefer hard evidence to unicorn tears and rainbow wishes.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼